Target delineation for esophageal cancer

Journal of Women's Imaging

Volumn 5, Issue 4, 2003, Pages 177-186

  Liao, Zhongxing ^a,b   Liu, Helen ^a   Komaki, Ritsuko ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b NONE   (United States)

Author keywords

Esophageal carcinoma; Image guided radiotherapy; Target delineation

Indexed keywords

ANTINEOPLASTIC AGENT;

ACCURACY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ESOPHAGOGRAPHY; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; ESOPHAGUS MOTILITY; ESOPHAGUS RESECTION; FEMALE; HUMAN; IMAGE ANALYSIS; LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RESPIRATORY FUNCTION; REVIEW; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 1542619837     PISSN: 1084824X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00130747-200311000-00003     Document Type: Review

References (27)

1. Devesa S, Blot W, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049-2053.
2. Siewert J, Fink U, Beckurts K, et al. Surgery of squamous cell carcinoma of the esophagus. Ann Oncol. 1994;5:1-7.
3. Orringer M, Marshall B, Stirling M. Transhiatal esophagectomy for benign and malignant disease. J Thorac Cardiovasc Surg. 1993;105:265-277.
4. Kelsen D, Iison D, Minsky B, et al. Phase I trial of combined modality therapy for locallized esophageal cancer: Radiation therapy + concurrent cisplatin and escalating doses of 96 hour infusional paclitaxel [abstract 1000]. Proc ASCO. 1998;17.
5. Cooper J, Guo M, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA. 1999;281:1623-1627.
6. Manual CS. American Joint Committee on Cancer. 6 ed. Chicago, III: Springer-Verlag; 2001.
7. DeNardi FG, Riddell RH. The normal esophagus. Am J Surg Pathol. 1991;15:296-309.
8. Drudi FM, Trippa F, Cascone F, et al. Esophagogram and CT vs endoscopic and surgical specimens in the diagnosis of esophageal carcinoma. Radiol Med. 2002;103:344-352.
9. Grimm H, Binmoeller KF, Hamper K, et al. Accuracy of endoscopic altrasound (EUS) in preoperative staging of esophageal carcinoma [abstract]. Endoscopy. 1992;24:652.
10. Hordijk ML, Zander H, van Blankenstein M, et al. Influence of tumor stenosis on the accuracy of endosonography in preoperative T staging of esophageal cancer. Endoscopy. 1993;25:171-175.
11. Kallimanis GE, Gupta PK, al-Kawas FH, et al. Endoscopic ultrasound for staging esophageal cancer, with or without dilation, is clinically important and safe. Gastrointest Endosc. 1995;41:540-546.
12. Rosch T, Lorenz R, Zenker K, et al. Local staging and assessment of resectability in carcinoma of the esophagus, stomach, and duodenum by endoscopic ultrasonography. Gastrointest Endosc. 1992;38: 460-467.
13. Tio TL, Cohen P, Coene PP, et al. Endosonography and computed tomography of esophageal carcinoma. Preoperative classification compared to the new (1987) TNM system. Gastroenterology. 1989; 96:1478-1486.
14. Rosch T. Endosonographic staging of esophageal cancer: a review of literature results. Gastrointest Edosc Clin N Am. 1995;5:537-547.
15. Lightdale C. Practice Guidelines: esophageal cancer. Am J Gastroenterol. 1999;94:20-29.
16. Yoshikane H, Tsukamoto Y, Niwa Y, et al. Superficial esophageal carcinoma: evaluation by endoscopic ultrasonography. Am J Gastroenterol. 1994; 89:702-707.
17. Fok M, Sham J, Choy D, et al. Postoperative radiotherapy for carcinoma of the esophagus: A prospective, randomized controlled study. Surgery. 1993; 113:138-147.
18. Rice T. Clinical Staging of esophageal carcinoma CT, EUS, and PET. Chest Surg Clin N Am. 2000;10:471-485.
19. Saunders HS, Wolfman NT, Ott DJ. Esophageal cancer. Radiologic staging. Radiol Clin North Am. 1997;35:281-294.
20. Van Overhagen H, Bechker C. Diagnosis and staging of carcinoma of the esophagus and gastroesophageal junction, and detection of postoperative recurrence, by computer tomography. In: Meyers MA, ed. Neoplasms of the Digestive Tract: Imaging, Staging and Management. Philadelphia, Pa: Lippincott-Raven; 1998:31-48.
21. Flanagan FL, Dehdashti F, Siegel BA, et al. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. Am J Roentgenol. 1997;168:417-424.
22. Rankin SC, Taylor H, Cook GJ, et al. Computed tomography and positron emission tomography in the pre-operative staging of esophageal carcinoma. Clin Radiol. 1998;53:659-665.
23. Mauer AM, Weichselbaum RR. Multimodality therapy for carcinoma of the esophagus. In: Steele GD, Phillips TL, Chabner BA, eds. American Cancer Society Atlas of Clinical Oncology Cancer of the Upper Gastrointestinal Tract. Chicago, III: BC Decker Inc.; 2002.
24. Miller C. Carcinoma of the esophagus and gasric cardia. Br J Cancer. 1962;49:507-522.
25. Elkon D, Lee MS, Hendrickson FR. Carcinoma of the esophagus: sites of recurrence and palliative benefits after definitive radiotherapy. Int J Radiat Oncol Biol Phys. 1978;4:615-620.
26. Herskovic A, Martz K, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326:1593-1598.
27. Konski A, Chen L, Doss M, et al. Preliminary analysis of incorporating PET and MRI scans into the treatment planning process for esophageal carcinoma. American Radium Society 85th Annual Meeting; 2003; Houston, Texas.